Sorafekast 200mg Sorafenib Tablet: A Key Treatment for Advanced Liver Cancer in the Philippines
In the Philippines, liver cancer remains one of the leading causes of cancer-related deaths, making early diagnosis and effective treatment essential. At RxLane, we’re proud to offer Sorafekast 200mg Sorafenib Tablets, a cutting-edge therapy for the treatment of advanced liver cancer, including hepatocellular carcinoma (HCC). Sorafekast, containing the active ingredient Sorafenib, is a proven oral multikinase inhibitor designed to target cancer cell proliferation and angiogenesis.
What is Sorafekast (Sorafenib)?
Sorafekast is an oral medication that contains Sorafenib, a potent drug used in the treatment of various cancers, especially liver cancer (hepatocellular carcinoma), renal cell carcinoma (RCC), and differentiated thyroid carcinoma. Sorafenib works by inhibiting multiple kinases involved in tumor cell growth and angiogenesis (the formation of new blood vessels that tumors need to grow).
How Sorafekast Sorafenib 200mg Tablet Works
Sorafekast targets the Raf kinase pathway, which plays a critical role in tumor cell proliferation, survival, and metastasis. Sorafenib also inhibits the vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR), both of which are crucial for angiogenesis in cancerous tissues. By blocking these pathways, Sorafekast helps to:
- Inhibit tumor cell growth
- Reduce blood supply to tumors
- Prevent cancer cell spread
Indications for Sorafekast 200mg Sorafenib Tablet
In the Philippines, Sorafekast 200mg Sorafenib Tablets are approved for use in patients with:
- Advanced Hepatocellular Carcinoma (HCC): Sorafekast is the standard of care for patients with advanced liver cancer who are not candidates for surgery or liver transplant.
- Renal Cell Carcinoma (RCC): For patients with advanced kidney cancer, Sorafekast can significantly improve overall survival.
- Differentiated Thyroid Cancer (DTC): When other treatment options have been exhausted, Sorafenib is used to manage advanced or metastatic DTC.
Benefits of Sorafekast for Filipino Patients
- Improved Survival Rates: In clinical trials, Sorafenib has demonstrated significant benefits in overall survival (OS) and progression-free survival (PFS) for patients with advanced HCC and other cancers. This is especially important in regions like the Philippines, where liver cancer is diagnosed at more advanced stages.
- Oral Convenience: Sorafekast is an oral medication, making it more convenient for patients compared to intravenous treatments. This helps improve patient adherence to the treatment regimen and overall quality of life.
- Targeted Action: By targeting specific signaling pathways involved in cancer growth and spread, Sorafekast offers a more precise and effective treatment compared to traditional chemotherapy, reducing the risk of side effects associated with non-targeted therapies.
- Addressing a High Medical Need: Liver cancer in the Philippines is often diagnosed at later stages due to limited access to early screening and diagnostic tools. Sorafekast provides a treatment option that can help manage the disease in its advanced stages, giving patients more time and potentially improving their quality of life.
Dosage and Administration
The recommended dosage of Sorafekast 200mg Sorafenib Tablets is 400 mg (two 200mg tablets) taken twice daily, with or without food. Patients should be monitored regularly for potential side effects, including liver function and blood pressure, and the dosage may be adjusted based on individual tolerance.
Side Effects and Management of Sorafenib 200mg Tablet Philippines
Like all medications, Sorafekast may cause side effects. Common side effects include:
- Fatigue
- Diarrhea
- Rashes
- Loss of appetite
- High blood pressure
Serious side effects, though rare, may include liver toxicity, bleeding, and heart problems. It is crucial for patients to follow their healthcare provider’s recommendations and undergo regular monitoring during treatment to manage these side effects.
Accessing Sorafekast Sorafenib 200mg Tablet in the Philippines
At RxLane, we are committed to providing patients with the best possible access to life-saving medications like Sorafekast. Sorafekast 200mg Sorafenib Tablets are available in pharmacies across the Philippines, including key cities such as Metro Manila, Cebu, Davao, Quezon City, Makati, Taguig, Cagayan de Oro, Iloilo, Dumaguete, and Zamboanga. If you or a loved one has been diagnosed with advanced liver cancer, renal cell carcinoma, or differentiated thyroid cancer, speak with your doctor to see if Sorafekast is the right treatment option for you.
Sorafekast 200mg Sorafenib Tablets offer Filipino patients a powerful treatment option for managing advanced liver cancer and other malignancies. With proven efficacy, a convenient oral form, and a targeted action against cancer pathways, Sorafekast provides hope for better survival outcomes. RxLane is proud to be a part of the fight against cancer in the Philippines, offering innovative solutions to improve the lives of those affected by serious conditions.
Customer Reviews
There are no reviews yet.